130 related articles for article (PubMed ID: 36764340)
1. New insight of human-IgH 3'regulatory regions in immunoglobulins switch.
Cianci R; Mancino G; Galli E; Serone E; Massoud R; D'Addabbo P; Poscia A; Borghetti A; Porzio O; Marmo R; Gambassi G; Frezza D
Gene; 2023 Apr; 862():147254. PubMed ID: 36764340
[TBL] [Abstract][Full Text] [Related]
2. The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism.
Serone E; Daleno C; Principi N; Porretti L; Iacoacci V; Gargioli C; Magrini A; Massoud R; D'Addabbo P; Cattalini M; Giambra V; Plebani A; Esposito S; Frezza D
BMC Immunol; 2014 Nov; 15():45. PubMed ID: 25391515
[TBL] [Abstract][Full Text] [Related]
3. Association between Psoriasis and haplotypes of the IgH 3' Regulatory Region 1.
D'Addabbo P; Serone E; Esposito M; Vaccari G; Gargioli C; Frezza D; Bianchi L
Gene; 2018 Aug; 669():47-51. PubMed ID: 29802990
[TBL] [Abstract][Full Text] [Related]
4. Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3'Regulatory Region.
D'Addabbo P; Scascitelli M; Giambra V; Rocchi M; Frezza D
BMC Evol Biol; 2011 Mar; 11():71. PubMed ID: 21406099
[TBL] [Abstract][Full Text] [Related]
5. Locus suicide recombination actively occurs on the functionally rearranged IgH allele in B-cells from inflamed human lymphoid tissues.
Dalloul I; Boyer F; Dalloul Z; Pignarre A; Caron G; Fest T; Chatonnet F; Delaloy C; Durandy A; Jeannet R; Lereclus E; Boutouil H; Aldigier JC; Péron S; Le Noir S; Cook-Moreau J; Cogné M
PLoS Genet; 2019 Jun; 15(6):e1007721. PubMed ID: 31199803
[TBL] [Abstract][Full Text] [Related]
6. The immunoglobulin heavy chain super enhancer controls class switch recombination in developing B cells.
Dauba A; Näser E; Andrieux D; Cogné M; Denizot Y; Khamlichi AA
Sci Rep; 2024 Mar; 14(1):7370. PubMed ID: 38548819
[TBL] [Abstract][Full Text] [Related]
7. The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice.
Saad F; Saintamand A; Cogné M; Denizot Y
Oncotarget; 2015 Aug; 6(24):20302-11. PubMed ID: 25980500
[TBL] [Abstract][Full Text] [Related]
8. Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia.
Frezza D; Giambra V; Mattioli C; Piccoli K; Massoud R; Siracusano A; Di Giannantonio M; Birshtein BK; Rubino IA
Int J Immunopathol Pharmacol; 2009; 22(1):115-23. PubMed ID: 19309558
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a quadruplex structure in the polymorphic hs1.2 enhancer of the immunoglobulin heavy chain 3' regulatory regions and its conservation in mammals.
Sette M; D'Addabbo P; Kelly G; Cicconi A; Micheli E; Cacchione S; Poma A; Gargioli C; Giambra V; Frezza D
Biopolymers; 2016 Nov; 105(11):768-78. PubMed ID: 27287611
[TBL] [Abstract][Full Text] [Related]
10. Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration.
Giambra V; Cianci R; Lolli S; Mattioli C; Tampella G; Cattalini M; Kilic SS; Pandolfi F; Plebani A; Frezza D
J Immunol; 2009 Dec; 183(12):8280-5. PubMed ID: 20007591
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the importance of the palindromic architecture of the immunoglobulin heavy-chain 3' regulatory region.
Saintamand A; Vincent-Fabert C; Garot A; Rouaud P; Oruc Z; Magnone V; Cogné M; Denizot Y
Nat Commun; 2016 Feb; 7():10730. PubMed ID: 26883548
[TBL] [Abstract][Full Text] [Related]
12. IgH 3' regulatory region increases ectopic class switch recombination.
Le Noir S; Bonaud A; Hervé B; Baylet A; Boyer F; Lecardeur S; Oruc Z; Sirac C; Cogné M
PLoS Genet; 2021 Feb; 17(2):e1009288. PubMed ID: 33556079
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus.
Frezza D; Tolusso B; Giambra V; Gremese E; Marchini M; Nowik M; Serone E; D'Addabbo P; Mattioli C; Canestri S; Petricca L; D'Antona G; Birshtein BK; Scorza R; Ferraccioli G
Ann Rheum Dis; 2012 Aug; 71(8):1309-15. PubMed ID: 22294636
[TBL] [Abstract][Full Text] [Related]
14. The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease.
Cianci R; Lolli S; Pagliari D; Gambassi G; Frosali S; Marmo R; Melioli G; Orlando A; Newton EE; Serone E; Landolfi R; Pandolfi F; Frezza D
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3618-27. PubMed ID: 27649663
[TBL] [Abstract][Full Text] [Related]
15. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination.
Delgado-Benito V; Rosen DB; Wang Q; Gazumyan A; Pai JA; Oliveira TY; Sundaravinayagam D; Zhang W; Andreani M; Keller L; Kieffer-Kwon KR; Pękowska A; Jung S; Driesner M; Subbotin RI; Casellas R; Chait BT; Nussenzweig MC; Di Virgilio M
Mol Cell; 2018 Nov; 72(4):636-649.e8. PubMed ID: 30293785
[TBL] [Abstract][Full Text] [Related]
16. Specific immunoglobulins to soybean hull allergens in soybean asthma.
Codina RM; Calderón E; Lockey RF; Fernández-Caldas E; Rama R
Chest; 1997 Jan; 111(1):75-80. PubMed ID: 8995996
[TBL] [Abstract][Full Text] [Related]
17. Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes.
Vincent-Fabert C; Fiancette R; Pinaud E; Truffinet V; Cogné N; Cogné M; Denizot Y
Blood; 2010 Sep; 116(11):1895-8. PubMed ID: 20538806
[TBL] [Abstract][Full Text] [Related]
18. Association between IgH enhancer hs1.2 and type 1 diabetes.
Cianci R; D'Addabbo P; Gambassi G; Lolli S; Serone E; Rizzi A; Pitocco D; Pandolfi F; Frezza D
Acta Diabetol; 2018 May; 55(5):443-448. PubMed ID: 29441414
[TBL] [Abstract][Full Text] [Related]
19. Evolutive emergence and divergence of an Ig regulatory node: An environmental sensor getting cues from the aryl hydrocarbon receptor?
D'Addabbo P; Frezza D; Sulentic CEW
Front Immunol; 2023; 14():996119. PubMed ID: 36817426
[TBL] [Abstract][Full Text] [Related]
20. The IgH locus 3' cis-regulatory super-enhancer co-opts AID for allelic transvection.
Le Noir S; Laffleur B; Carrion C; Garot A; Lecardeur S; Pinaud E; Denizot Y; Skok J; Cogné M
Oncotarget; 2017 Feb; 8(8):12929-12940. PubMed ID: 28088785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
